"Cigarette smoke and cancer," Journal of Oncology (Vol: , Issue: , Page ) - 2011
"Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer," Cancer Research (Vol: 70, Issue: 20, Page 7992-8002) - 2010
"ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21 (Cancer Research (2010) 70, (3239-3248) DOI:10.1158/0008-5472. CAN-09-3186)," Cancer Research (Vol: 70, Issue: 11, Page 4785-) - 2010
"ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21," Cancer Research (Vol: 70, Issue: 8, Page 3239-3248) - 2010
"CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity," Prostate (Vol: 70, Issue: 4, Page 433-442) - 2010
"Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization," Proceedings of the National Academy of Sciences of the United States of America (Vol: 106, Issue: 42, Page 17910-17915) - 2009
"Prostate cancer - Associated gene expression alterations determined from needle biopsies," Clinical Cancer Research (Vol: 15, Issue: 9, Page 3135-3142) - 2009
"Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells," Proceedings of the National Academy of Sciences of the United States of America (Vol: 106, Issue: 7, Page 2353-2358) - 2009
"Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth," Proceedings of the National Academy of Sciences of the United States of America (Vol: 105, Issue: 50, Page 19579-19586) - 2008
"The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D 3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells," Clinical Cancer Research (Vol: 14, Issue: 11, Page 3562-3570) - 2008
"Combination strategy targeting the hypoxia inducible factor-1 α with mammalian target of rapamycin and histone deacetylase inhibitors," Clinical Cancer Research (Vol: 14, Issue: 11, Page 3589-3597) - 2008
"Platelets take up the monoclonal antibody bevacizumab," Clinical Cancer Research (Vol: 13, Issue: 18, Page 5341-5347) - 2007
"The N-Myc down regulated gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin," PLoS ONE (Vol: 2, Issue: 9, Page ) - 2007
"Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models," Prostate (Vol: 67, Issue: 11, Page 1182-1193) - 2007
"Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs," Cancer Chemotherapy and Pharmacology (Vol: 60, Issue: 3, Page 329-339) - 2007
"Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model," Clinical Cancer Research (Vol: 13, Issue: 14, Page 4201-4208) - 2007
"Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma," Molecular Cancer Therapeutics (Vol: 6, Issue: 1, Page 70-81) - 2007
"Identification of ABR-215050 as lead second generation quinoline-3- carboxamide anti-angiogenic agent for the treatment of prostate cancer," Prostate (Vol: 66, Issue: 16, Page 1768-1778) - 2006
"Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α," Cancer Research (Vol: 66, Issue: 17, Page 8814-8821) - 2006
"Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target," Journal of Medicinal Chemistry (Vol: 49, Issue: 9, Page 2677-2680) - 2006
